Pennsylvania has enacted new legislation restricting the sale of cosmetic products developed or manufactured using animal testing. On 22 October 2026, Governor Josh Shapiro signed Senate Bill 381 (SB 381) into law as Act No. 92 of 2026.
The legislation prohibits manufacturers from selling or offering for sale in Pennsylvania cosmetic products developed or manufactured using animal tests conducted or commissioned by the manufacturer or its suppliers on or after 1 January 2027, subject to specified exemptions.
Although 1 January 2027 is the relevant animal testing cut-off date, the legislation will formally take effect on 20 April 2027, 180 days after its enactment.
The new requirements are particularly relevant to cosmetic manufacturers, ingredient suppliers, importers, distributors and brand owners supplying products to the Pennsylvania market.
The legislation also highlights the growing importance of evaluating state-specific animal testing restrictions alongside applicable federal cosmetic safety requirements.
What Does Pennsylvania’s New Animal Testing Law Cover?
The new provisions were introduced under Chapter 58A of Title 35 of the Pennsylvania Consolidated Statutes.
The restrictions concerning cosmetic products are addressed in Subchapter B, particularly Sections 58A21 and 58A22.
The legislation covers animal testing associated with both finished cosmetic products and ingredients used in their formulation.
Key areas include:
- Animal testing conducted during cosmetic product development or manufacturing.
- Testing performed on ingredients used in cosmetic formulations.
- Tests conducted or commissioned by manufacturers or their suppliers.
- The sale or offer for sale of affected cosmetic products in Pennsylvania.
- Specific exemptions for qualifying medical and regulatory testing activities.
As a result, manufacturers should evaluate not only their internal testing practices but also relevant animal testing activities throughout their ingredient supply chains.
Key Dates: 1 January 2027 and 20 April 2027
The legislation establishes two different dates that must be distinguished.
| Date | Regulatory significance |
| 22 October 2026 | SB 381 was signed into law as Act No. 92 of 2026. |
| 1 January 2027 | Cut-off date for animal testing covered by the prohibition. |
| 20 April 2027 | The legislation formally takes effect. |
What Does the 1 January 2027 Cut-Off Date Mean?
Animal tests conducted on cosmetic products or ingredients before 1 January 2027 are excluded from the new prohibition.
The legislation also allows manufacturers to continue reviewing, assessing and retaining data generated through previous animal testing.
Therefore, the existence of historical animal testing data does not automatically make a cosmetic product subject to the new sales prohibition.
What Happens on 20 April 2027?
From 20 April 2027, manufacturers will be prohibited from selling or offering for sale cosmetics covered by the legislation where relevant animal testing was conducted or commissioned on or after 1 January 2027, unless an applicable exemption is satisfied.
Companies should therefore assess both the timing of the testing and whether the relevant legal conditions or exemptions apply.
How Does the Law Define Cosmetics, Animal Testing and Manufacturers?
Pennsylvania’s legislation adopts the federal definition of cosmetics under Section 201(i) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Cosmetics generally include products intended to be applied to the human body for cleansing, beautifying, promoting attractiveness or altering appearance.
Under the new Pennsylvania law, an animal test involves the internal or external application of a cosmetic product or cosmetic ingredient to a body part of a live non-human vertebrate animal.
Who Qualifies as a Manufacturer?
The legislation uses a definition linked to the entity identified on the cosmetic product label.
Under 21 CFR 701.12, the name appearing on the label may identify the manufacturer, packer or distributor.
These entities may therefore fall within the manufacturer’s definition for purposes of the Pennsylvania legislation.
Which Suppliers Are Covered?
A supplier includes an entity that provides an ingredient used in the manufacturer’s cosmetic formulation, directly or through a third party.
This definition makes supply chain due diligence particularly important, as relevant testing activities may occur outside the cosmetic brand’s own facilities.
What Exemptions Apply to Pennsylvania’s Animal Testing Restrictions?
Although the legislation restricts sales of cosmetics associated with certain animal tests, it provides exemptions under specified circumstances.
The applicability of an exemption must be evaluated against the precise statutory conditions.
1. Medical Research
The restrictions do not apply to animal research conducted for qualifying medical research purposes.
However, the medical research definition includes specific limitations.
The fact that an ingredient has historically been used in a pharmaceutical product does not automatically mean that all subsequent animal testing involving that ingredient qualifies for the exemption.
2. Testing Required by Federal or State Regulatory Authorities
Certain animal tests required by a federal or state regulatory authority may qualify for an exemption if all applicable statutory conditions are met.
These include:
- The ingredient is widely used and cannot be replaced by another ingredient.
- A specific human health concern associated with the ingredient justifies the testing and is supported by a research protocol.
- No suitable non-animal testing method or strategy is accepted by the relevant regulatory authority for obtaining the required information.
The exemption is therefore conditional and should not be interpreted as a general allowance for all tests requested by regulatory agencies.
3. Testing Conducted Outside the United States
Certain animal tests conducted outside the United States to satisfy a foreign regulatory requirement may also qualify for an exemption.
However, evidence generated through such testing must not be relied upon to substantiate cosmetic product safety under applicable federal or state regulations.
Companies should carefully assess the purpose of the testing and how its results are subsequently used.
4. Testing for Non-Cosmetic Regulatory Purposes
The legislation also provides an exemption for certain animal testing conducted to satisfy regulatory requirements unrelated to cosmetics.
However, using animal testing evidence generated after 1 January 2027 to substantiate cosmetic safety is subject to additional conditions.
These include the absence of recognised non-animal testing methods for relevant safety endpoints, documentation demonstrating the non-cosmetic purpose and an established history of non-cosmetic use of the ingredient.
5. Historical Animal Testing Data
The prohibition does not apply to animal tests performed before 1 January 2027.
Manufacturers may continue to review, assess and retain previously generated animal testing information.
This provision distinguishes historical scientific data from new testing activities conducted after the statutory cut-off date.
What Non-Animal Testing Alternatives Are Available?
Animal testing alternatives are increasingly important in cosmetic ingredient safety assessment and product development.
These approaches are commonly referred to as New Approach Methodologies (NAMs).
Examples include:
- In vitro testing using human cells and tissues.
- Reconstructed human epidermis models.
- Validated OECD testing methods for relevant toxicological endpoints.
- Computational toxicology and predictive modelling.
- Quantitative Structure–Activity Relationship (QSAR) approaches.
- Read-across and integrated testing strategies.
However, no single alternative method can necessarily address every potential toxicological hazard.
Manufacturers should assess whether the chosen method is scientifically suitable for the relevant safety endpoint and accepted under applicable regulatory requirements.
How Does Pennsylvania’s Law Relate to Federal Cosmetic Regulations?
Cosmetic products marketed in the United States are subject to federal requirements under the FD&C Act and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), where applicable.
Pennsylvania’s new law introduces an additional state-level sales restriction concerning products associated with certain animal testing activities.
Compliance with federal FDA requirements does not automatically establish compliance with Pennsylvania’s legislation.
Similarly, satisfying Pennsylvania’s animal testing restrictions does not remove other applicable federal or state obligations.
Cosmetic manufacturers should therefore review requirements at both levels when developing compliance programmes for the U.S. market.
How Should Cosmetic Manufacturers and Suppliers Prepare?
Companies manufacturing, importing, distributing or marketing cosmetic products in Pennsylvania should consider reviewing their existing product development and supply chain documentation.
1. Review Cosmetic Product Portfolios
Identify products currently marketed or intended for sale in Pennsylvania.
Review the ingredients used and relevant animal testing histories.
2. Strengthen Supplier Due Diligence
Request updated information from cosmetic ingredient suppliers concerning animal testing performed or commissioned on the relevant ingredients.
3. Verify Animal Testing Dates
Distinguish testing conducted before 1 January 2027 from testing carried out on or after the cut-off date.
4. Document Applicable Exemptions
Where animal testing is required for medical or non-cosmetic regulatory purposes, maintain documentation supporting the applicable statutory exemption.
5. Evaluate Alternative Safety Testing Strategies
Consider scientifically appropriate non-animal testing methods during product development and ingredient safety assessment.
6. Monitor State-Level Regulatory Developments
Review the animal testing requirements applicable to other U.S. states where products are marketed.
These activities can help companies identify potential compliance risks and prepare for the implementation of the Pennsylvania restrictions.
What Are the Consequences of Non-Compliance?
Pennsylvania’s legislation provides enforcement mechanisms for violations.
The Pennsylvania Attorney General may initiate civil proceedings in the appropriate courts to seek injunctive relief or other remedies deemed appropriate by the court.
The legislation does not create a private right of action for individuals to enforce its provisions.
Companies should nevertheless consider the possible legal and commercial implications of non-compliance, including restrictions affecting sales of relevant cosmetic products.
What Does Pennsylvania’s Animal Testing Ban Mean for the Cosmetics Industry?
Pennsylvania’s Act No. 92 of 2026, enacted on 22 October 2026, introduces new restrictions on the sale of cosmetic products developed or manufactured using animal testing.
The legislation covers certain tests conducted or commissioned by manufacturers and their suppliers on or after 1 January 2027.
The law will formally take effect on 20 April 2027, with specific exemptions for qualifying medical research, regulatory testing and other activities.
For cosmetic manufacturers, ingredient suppliers and companies supplying the U.S. market, the legislation highlights the importance of reviewing animal testing histories, supplier documentation and product development processes.
Businesses should assess their current practices against the new requirements and monitor applicable state-level cosmetic regulations to support continued market access.
Need Support with U.S. Cosmetics Regulatory Compliance?
Obelis Türkiye supports cosmetic companies in evaluating applicable U.S. regulatory requirements, reviewing ingredient and product compliance documentation and managing regulatory compliance processes.
For further information, tailored regulatory assistance or a quotation, contact us through our website or connect with us on LinkedIn and Instagram.